title: Identification of vascular endothelial growth factor receptor-binding protein in the venom of eastern cottonmouth. A new role of snake venom myotoxic Lys49-phospholipase A2.
abstract: Vascular endothelial growth factor (VEGF165) and its receptor KDR (kinase insert domain-containing receptor) are central regulators of blood vessel formation. We herein report a KDR-binding protein we have isolated in the venom of eastern cottonmouth (Agkistrodon piscivorus piscivorus). Sequence analysis revealed the isolated KDR-binding protein (designated KDR-bp) is identical to Lys49-phosholipase A2 (Lys49PLA2), an inactive PLA2 homologue with strong myotoxicity, in which Lys49 substitutes Asp49, a key residue for binding the essential cofactor Ca2+. KDR-bp binds to the extracellular domain of KDR with subnanomolar affinity. KDR-bp also binds to a lesser extent with Flt-1 and IgG but not to other receptors with similar immunoglobulin-like domain structures such as platelet-derived growth factor receptor alpha. The interaction between KDR-bp and KDR was blocked by VEGF165, and KDR-bp specifically inhibited VEGF165-stimulated endothelial cell proliferation, indicating KDR-bp is an antagonistic ligand for KDR. Lys49PLA2s from another snake venom were found to exhibit similar receptor binding properties to KDR-bp. This is the first report to demonstrate that an exogenous factor antagonizes VEGF and its receptor system. Our observation offers further insight into the as yet unknown molecular mechanism of myotoxic activity of snake venom Lys49PLA2s. Furthermore, KDR-bp would make a valuable tool for studying the structure and function of KDR, such as that expressed on skeletal muscle cells.
authors: Department of Biochemistry, Meiji Pharmaceutical University, 2-522-1, Noshio, Kiyose, Tokyo 204-8588, Japan.
authors: Yasuo
authors: Y
authors: Yamazaki
authors: Yukiko
authors: Y
authors: Matsunaga
authors: Yuta
authors: Y
authors: Nakano
authors: Takashi
authors: T
authors: Morita
mesh_terms: D017836:Agkistrodon; D000595:Amino Acid Sequence; D000818:Animals; D001224:Aspartic Acid / Q000737:chemistry; D002118:Calcium / Q000737:chemistry; D004305:Dose-Response Relationship, Drug; D004591:Electrophoresis, Polyacrylamide Gel; D054501:Group II Phospholipases A2; D007074:Immunoglobulin G / Q000737:chemistry; D007700:Kinetics; D008024:Ligands; D008239:Lysine / Q000737:chemistry; D008969:Molecular Sequence Data; D018482:Muscle, Skeletal / Q000378:metabolism; D009498:Neurotoxins / Q000737:chemistry; D010741:Phospholipases A / Q000737:chemistry / Q000502:physiology*; D054467:Phospholipases A2; D010766:Phosphorylation; D011485:Protein Binding; D017434:Protein Structure, Tertiary; D011506:Proteins / Q000737:chemistry; D030162:Reptilian Proteins; D017422:Sequence Analysis, DNA; D013997:Time Factors; D042461:Vascular Endothelial Growth Factor A / Q000737:chemistry; D040301:Vascular Endothelial Growth Factor Receptor-2 / Q000737:chemistry; D014757:Viper Venoms / Q000737:chemistry
chemical_list: D007074:Immunoglobulin G; D008024:Ligands; D009498:Neurotoxins; D011506:Proteins; D030162:Reptilian Proteins; D042461:Vascular Endothelial Growth Factor A; D014757:Viper Venoms; D001224:Aspartic Acid; D040301:Vascular Endothelial Growth Factor Receptor-2; D010741:Phospholipases A; D054501:Group II Phospholipases A2; C504244:KDR-binding protein, Agkistrodon piscivorus; D054467:Phospholipases A2; C061056:myotoxin II, Bothrops asper; D008239:Lysine; D002118:Calcium